Doctor Evidence, LLC, Santa Monica, California.
University of Michigan Health System, College of Pharmacy, University of Michigan, Ann Arbor.
Clin Infect Dis. 2019 May 2;68(10):1777-1782. doi: 10.1093/cid/ciy797.
Antimicrobial stewardship programs (ASPs) are recommended by the Centers for Disease Control and Prevention and World Health Organization and mandated by the Joint Commission to curb antimicrobial resistance. However, <50% of institutions have optimal ASPs in place. Building on its experience of antimicrobial stewardship (AMS) advocacy, the Infectious Diseases Society of America (IDSA) developed the AMS Centers of Excellence (CoE) program, which will serve as a conduit to share best practices and highlight the standards for other hospitals to achieve in order to advance the field of AMS. A designation of CoE signifies that these institutions deliver high-quality care consistently, serve as the "gold" standard for executing novel AMS principles, and demonstrate commitment to their ASP. Here, we describe the process and purpose of designating institutions as AMS CoEs, provide awareness to clinicians on opportunities available through IDSA with this CoE designation, and discuss the evolution of the program.
抗菌药物管理计划（ASPs）得到了疾病控制与预防中心和世界卫生组织的推荐，并被联合委员会授权以遏制抗菌药物耐药性。然而，<50%的机构实施了最佳的 ASP。在美国传染病学会（IDSA）开展抗菌药物管理（AMS）宣传的基础上，开发了抗菌药物管理卓越中心（CoE）计划，该计划将作为一个渠道，分享最佳实践，并强调其他医院为推进 AMS 领域而应达到的标准。CoE 的指定意味着这些机构始终如一地提供高质量的护理，是执行新的 AMS 原则的“黄金”标准，并表明对其 ASP 的承诺。在这里，我们描述了指定机构为 AMS CoE 的过程和目的，让临床医生了解通过 IDSA 的 CoE 指定可以获得的机会，并讨论了该计划的演变。
